Related references
Note: Only part of the references are listed.MicroRNAs and Colon and Rectal Cancer: Differential Expression by Tumor Location and Subtype
Martha L. Slattery et al.
GENES CHROMOSOMES & CANCER (2011)
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Alexander Link et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis
Yutaka Hashimoto et al.
CARCINOGENESIS (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney et al.
CLINICAL CANCER RESEARCH (2010)
Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer
Murugan Kalimutho et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis
Ying Xin Wang et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
Yue Chen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states
Aaron L. Sarver et al.
BMC CANCER (2009)
Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
Douglas R. Hurst et al.
CANCER RESEARCH (2009)
DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
Bilian Jin et al.
CANCER RESEARCH (2009)
Epigenetic regulation of microRNA expression in colorectal cancer
Eva Bandres et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer
Zhi Ming Huang et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration
Ahmed Yaqinuddin et al.
Cancer Cell International (2008)
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
Minoru Toyota et al.
CANCER RESEARCH (2008)
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms
Federica Felicetti et al.
CANCER RESEARCH (2008)
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
Shingo Mitomo et al.
CANCER SCIENCE (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Deregulated expression of miR-106a predicts survival in human colon cancer patients
Raquel Diaz et al.
GENES CHROMOSOMES & CANCER (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer
U. Lehmann et al.
JOURNAL OF PATHOLOGY (2008)
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer
W. M. Grady et al.
ONCOGENE (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miR-148 targets human DNMT3b protein coding region
Anja M. Duursma et al.
RNA (2008)
MicroRNAs and cancer: Profile, profile, profile
Elisa Barbarotto et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma
Laura Gramantieri et al.
CANCER RESEARCH (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Amaia Lujambio et al.
CANCER RESEARCH (2007)
The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function
Bodo Brueckner et al.
CANCER RESEARCH (2007)
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
Gregory J. Hurteau et al.
CANCER RESEARCH (2007)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Suppression of intestinal neoplasia by deletion of Dnmt3b
HJ Lin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
MicroRNA expression in zebrafish embryonic development
E Wienholds et al.
SCIENCE (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Detecting colorectal cancer in stool with the use of multiple genetic targets
SM Dong et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
